Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by valueplaysonlyon Sep 24, 2013 5:18pm
206 Views
Post# 21764450

RE:AGM Continued

RE:AGM ContinuedYou  have wasted   ten  years of your life  on this.  This is a  POS.  There is a life cycle  to    holding drug stocks.  People  overpay  in phase 1  and  Phase  2   because  they are blue sky dreaming.   This    stock is done,  Zenith is done,  sell on any    BOUNCE  you can.

Power Corporation  has  just under 10  %  of Bellus Health Care,   BLU.  Today  I  can  buy that stock  with one phase 3 candidate and another in  Phase  2  for  75 %  LESS  THAN  WHAT  POWER CORPORATION   PAID FOR IT.

   They   already have a   partner paying all the costs of Kiacta for a  50    % stake. The burn rate is  low,  they are lean and cashed up  to take   Kiacta to  Phase   3.     Robert is prudent with the cash.  They  still   have the   neutricyclical  business  (  a  non   core asset )  that they can sell off  when  the market is favorable.


As   one of the most  skilled options traders  in the universe,  I  can tell  you  its  ALL  ABOUT THE TIMING.   RVX  is dead  money,  another  sad  little engine that coldn't   and  throwing good money after bad is never  sound financial  advice.

  Stick  with  VPO,  stock  picker to the stars,  the  oracle of Delphi  comes to  ME  for consultations.


BLU   is a 5  bagger in   the next 18  months  !!!!!













Bullboard Posts